Abstract:Aims/Purpose: To determine whether gene therapy using the modified tyrosine kinase receptors (insulin receptor or TrkB) can protect retinal ganglion cells (RGCs) and stimulate axon regeneration in glaucoma model mice. Methods: To examine the effects on the signalling pathways, Cos7 cells were transfected with intracellular region of insulin receptor (iIR) or TrkB (iTrkB) for 24 h, and immunoblot analysis was performed using antibodies against total and phosphorylated ERK and AKT. To evaluate their neuroprotective effects in vivo, the modified IR or TrkB was overexpressed in RGCs in GLAST knockout mice, a mouse model of normal tension glaucoma, by an intraocular injection of AAV‐iIR or AAV‐iTrkB. For optic nerve crush (ONC) model, AAV‐iIR or AAV‐iTrkB was injected into the mouse eyes 2 weeks before ONC. The number of surviving RGCs was examined by whole‐mount immunostaining of the retina with an RBPMS antibody. RGC dendrites were visualized by GFP labeling and quantified using the microscopy image analysis software IMARIS. Optic nerve regeneration was examined by the intraocular injection of Cholera Toxin Subunit B at 2 days before sacrifice. Results: iIR and iTrkB transfection in vitro both strongly induced phosphorylation of ERK and AKT, and in vivo, AAV‐iIR and AAV‐iTrkB both significantly increased the number of surviving RGCs in GLAST knockout mice and ONC mice. Moreover, AAV‐iIR and AAV‐iTrkB promoted axon regeneration in ONC mice and preserved the structure of RGC dendrites. Conclusions: Our system overcomes the small size limitation of the genome packaging in AAV and may be useful for the treatment of retinal and optic nerve degeneration. References Nishijima E, Honda S, Kitamura Y, Namekata K, Kimura A, Guo X, Azuchi Y, Harada C, Murakami A, Matsuda A, Nakano T, Parada LF, Harada T. Vision protection and robust axon regeneration in glaucoma models by membrane‐associated Trk receptors. Molecular Therapy 31(3), 810–824, 2023. doi: 10.1016/j.ymthe.2022.11.018

TrkB Signaling in Retinal Glia Stimulates Neuroprotection after Optic Nerve Injury

An Agonistic Trkb Mab Causes Sustained Trkb Activation, Delays Rgc Death, And Protects The Retinal Structure In Optic Nerve Axotomy And In Glaucoma

Overexpression of Brain-Derived Neurotrophic Factor Protects Large Retinal Ganglion Cells After Optic Nerve Crush in Mice

Different Optic Nerve Injury Sites Result in Different Responses of Retinal Ganglion Cells to Brain-Derived Neurotrophic Factor but Not Neurotrophin-4/5

Combination Brain-Derived Neurotrophic Factor and LINGO-1 Fusion Protein Promote Long-Term Survival to Retinal Ganglion Cells after Ocular Hypertension

Expression of Trka, Trkb, and Trkc in Injured and Regenerating Retinal Ganglion Cells of Adult Rats.

Changes in BDNF and neurotrophin receptor expression in degenerating and regenerating rat retinal ganglion cells

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective Whereas P75ntr Activity is Neurotoxic Through a Paracrine Mechanism

CNTF and BDNF Have Similar Effects on Retinal Ganglion Cell Survival but Differential Effects on Nitric Oxide Synthase Expression Soon after Optic Nerve Injury.

Nerve Growth Factor Helps Protect Retina in Experimental Retinal Detachment.

Neuroprotection and axon regeneration in glaucoma models by gene therapy using modified tyrosine kinase receptors

To explore the protective effect and mechanism of KLF7 overexpression on retinal ganglion cells after optic nerve crush in mice

TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury

A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia

Retinal ganglion cell neurotrophin receptor levels and trophic requirements following target ablation in the neonatal rat

Increasing Expression of Microglia in the Retina after Optic Nerve Transection in Rats

Single-cell RNA-sequencing analysis reveals enhanced non-canonical neurotrophic factor signaling in the subacute phase of traumatic brain injury

PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury

Brain-Derived Neurotrophic Factor Increases Synaptic Protein Levels via the MAPK/Erk Signaling Pathway and Nrf2/Trx Axis Following the Transplantation of Neural Stem Cells in a Rat Model of Traumatic Brain Injury

NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury